AlphaValue/Baader analyst Rishabh Kochar upgraded GSK to Buy from Add.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on GSK:
- GSK says PERLA ph. 2 trial achieved ‘very promising results’ on primary endpoint
- GSK says court has dismissed all cases alleging five remaining cancers in MDL
- Florida district court grants Sanofi, GSK summary judgment of Zantac suits
- GSK, Sanofi higher after U.S. court win related to Zantac, Bloomberg says
- GSK, Sanofi jump in afternoon trading